Startseite The need for evidence-based, non-drug medicine
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The need for evidence-based, non-drug medicine

  • Søren Ventegodt EMAIL logo , Gary Orr und Joav Merrick
Veröffentlicht/Copyright: 4. November 2011

Abstract

Evidence-based medicine (EBM) is defined as “the integration of best research evidence with clinical expertise and patient values.” EBM is based on three equally important key factors: i) the best available scientific evidence; ii) the physician’s experience and intuition; and, iii) the preferences and values of the patient. EBM uses a hierarchy of evidence and critical appraisal of the sources, which makes it possible to balance high quality evidence with documented effectiveness. A treatment that is more safe and effective, but less well documented may very well be the treatment of choice. Ethics (not putting the patient at risk of harm with a treatment if this can be avoided at all) is an important part of EBM. Many pharmaceutical drugs have a number needed to treat (NNT) of approximately 20 [NNT=20, confidence interval CI (5–50)] and the number needed to harm is less well understood and documented. The adverse effect profile of pharmacological agents can be more harmful than non-drug medicine. Most EBM-treatments are likely to be non-drug treatments in the future. There are six steps to the practice of EBM: i) the patients and the physician must work together to define the problem; ii) the patients and the physician must explore the patient’s values and preferences; iii) the information about the possible alternative medical interventions must be discussed and critically appraised; iv) the best, relevant evidence must be applied to the patient as a treatment or cure; v) together, the patient and the physician must evaluate how useful the intervention was; and vi) if the intervention did not help sufficiently, the process must begin again. In this review, we explain, in our opinion, how non-drug EBM should be practiced.


Corresponding author: Søren Ventegodt, MD, MMedSci, EU-MSc-CAM, Director, Quality of Life Research Center, Frederiksberg Alle 13A, 2tv, DK-1661 Copenhagen V, Denmark

Received: 2011-2-15
Revised: 2011-4-20
Accepted: 2011-5-2
Published Online: 2011-11-04
Published in Print: 2012-06-01

©2012 by Walter de Gruyter Berlin Boston

Heruntergeladen am 14.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ijamh.2012.017/html
Button zum nach oben scrollen